Immunogenicity, efficacy and safety of mRNACOVID-19 vaccines in people with multiple sclerosis who underwent treatment with autologous hematopoietic stem cell therapy

Authors
Category Primary study
Conference40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS 2024
Year 2024
This article has no abstract
Epistemonikos ID: 53614680f67d3c5f70faf1b5f09ffd04a21c29db
First added on: Mar 31, 2026